![John Pottage](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Pottage
Directeur/Membre du Conseil chez
SPERO THERAPEUTICS, INC.
Fortune : 87 750 $ au 31/07/2026
Profil
John C.
Pottage is currently Director at Global Virus Network since 2022, Director at Spero Therapeutics, Inc. since 2018, and Member-Global Safety Board at MMV Medicines for Malaria Venture.
Former positions include Director at Pardes Biosciences, Inc. from 2022 to 2023, SVP, Chief Scientific & Medical Officer at ViiV Healthcare Ltd. from 2009 to 2019, SVP & Head-Infectious Disease Medicine Development at GlaxoSmithKline LLC from 2008 to 2009, Chief Medical Officer & Senior Vice President at Achillion Pharmaceuticals, Inc. from 2002 to 2007, Medical Director at Vertex Pharmaceuticals (Canada), Inc. from 1998 to 2002, Associate Professor at Rush Medical College, and a role at Coopers & Lybrand LLP in 2004.
Education includes undergraduate studies at Colgate University and a doctorate from Saint Louis University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 23/06/2026 | 75 000 ( 0,13% ) | 87 750 $ | 31/07/2026 |
Postes actifs de John Pottage
| Sociétés | Poste | Début |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/09/2018 |
Global Virus Network
 Global Virus Network Miscellaneous Commercial ServicesCommercial Services Researches on essential and critical defense against viral disease | Directeur/Membre du Conseil | 03/05/2022 |
MMV Medicines for Malaria Venture
 MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services Develops antimalarial drugs | Corporate Officer/Principal | - |
Anciens postes connus de John Pottage
| Sociétés | Poste | Fin |
|---|---|---|
| PARDES BIOSCIENCES, INC. | Directeur/Membre du Conseil | 30/08/2023 |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Directeur Technique/Scientifique/R&D | 01/10/2019 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | 01/11/2009 |
| ACHILLION PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 14/05/2007 |
Vertex Pharmaceuticals (Canada), Inc.
 Vertex Pharmaceuticals (Canada), Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medicines for treating life threatening diseases | Directeur Technique/Scientifique/R&D | 01/05/2002 |
Formation de John Pottage
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments for infectious diseases | Health Technology |
Colgate University
 Colgate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services Develops antimalarial drugs | Commercial Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
Rush Medical College
 Rush Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Virus Network
Global Virus Network Miscellaneous Commercial ServicesCommercial Services Researches on essential and critical defense against viral disease | Commercial Services |
Saint Louis University School of Medicine
 Saint Louis University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vertex Pharmaceuticals (Canada), Inc.
Vertex Pharmaceuticals (Canada), Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medicines for treating life threatening diseases | Commercial Services |
Pardes Biosciences, Inc.
 Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops oral antiviral treatment for COVID-19 | Health Technology |
